Cargando…
Vaccination against SARS-CoV-2: a human enhancement story
BACKGROUND: Vaccination is an essential strategy for mitigating the COVID-19 pandemic. Besides its significance as a public health measure, vaccination is a sophisticated example of modern biotechnology. Since vaccination gives the human body an ability that it does not naturally possess, the questi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642743/ https://www.ncbi.nlm.nih.gov/pubmed/34901462 http://dx.doi.org/10.1186/s41231-021-00104-2 |
_version_ | 1784609731966402560 |
---|---|
author | Döbler, Niklas Alexander Carbon, Claus-Christian |
author_facet | Döbler, Niklas Alexander Carbon, Claus-Christian |
author_sort | Döbler, Niklas Alexander |
collection | PubMed |
description | BACKGROUND: Vaccination is an essential strategy for mitigating the COVID-19 pandemic. Besides its significance as a public health measure, vaccination is a sophisticated example of modern biotechnology. Since vaccination gives the human body an ability that it does not naturally possess, the question arises as to its classification as Human Enhancement. MAIN BODY: Exemplified on a selection of different definitions, we conclude that vaccinations may indeed be classified and treated as a form of Human Enhancement. This raises some ethical issues that are notorious in the broad field of Human Enhancement. A study with N = 67 participants revealed that vaccinations are perceived neither as a clear nor poor example of Human Enhancement. CONCLUSION: We argue that qualifying vaccination technology as Human Enhancement does not provide convincing arguments to reject vaccination. By examining the Human Enhancement debate and the similarities to the issue of vaccination shown here, policymakers can learn valuable lessons regarding mass vaccination programs’ current and future handling. |
format | Online Article Text |
id | pubmed-8642743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86427432021-12-06 Vaccination against SARS-CoV-2: a human enhancement story Döbler, Niklas Alexander Carbon, Claus-Christian Transl Med Commun Review BACKGROUND: Vaccination is an essential strategy for mitigating the COVID-19 pandemic. Besides its significance as a public health measure, vaccination is a sophisticated example of modern biotechnology. Since vaccination gives the human body an ability that it does not naturally possess, the question arises as to its classification as Human Enhancement. MAIN BODY: Exemplified on a selection of different definitions, we conclude that vaccinations may indeed be classified and treated as a form of Human Enhancement. This raises some ethical issues that are notorious in the broad field of Human Enhancement. A study with N = 67 participants revealed that vaccinations are perceived neither as a clear nor poor example of Human Enhancement. CONCLUSION: We argue that qualifying vaccination technology as Human Enhancement does not provide convincing arguments to reject vaccination. By examining the Human Enhancement debate and the similarities to the issue of vaccination shown here, policymakers can learn valuable lessons regarding mass vaccination programs’ current and future handling. BioMed Central 2021-12-04 2021 /pmc/articles/PMC8642743/ /pubmed/34901462 http://dx.doi.org/10.1186/s41231-021-00104-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Döbler, Niklas Alexander Carbon, Claus-Christian Vaccination against SARS-CoV-2: a human enhancement story |
title | Vaccination against SARS-CoV-2: a human enhancement story |
title_full | Vaccination against SARS-CoV-2: a human enhancement story |
title_fullStr | Vaccination against SARS-CoV-2: a human enhancement story |
title_full_unstemmed | Vaccination against SARS-CoV-2: a human enhancement story |
title_short | Vaccination against SARS-CoV-2: a human enhancement story |
title_sort | vaccination against sars-cov-2: a human enhancement story |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642743/ https://www.ncbi.nlm.nih.gov/pubmed/34901462 http://dx.doi.org/10.1186/s41231-021-00104-2 |
work_keys_str_mv | AT doblerniklasalexander vaccinationagainstsarscov2ahumanenhancementstory AT carbonclauschristian vaccinationagainstsarscov2ahumanenhancementstory |